Downregulation of cytokine-induced neutrophil chemoattractant and prolongation of rat liver allograft survival by interleukin-10.

作者: Xiao Ming Zou , Atsuhito Yagihashi , Koichi Hirata , Tetsuhiro Tsuruma , Takashi Matsuno

DOI: 10.1007/S005950050103

关键词:

摘要: We investigated whether the administration of recombinant human interleukin-10 (rhIL-10) regulates production cytokine-induced neutrophil chemoattractant (CINC) and improves graft survival in rat orthotopic liver transplantation (OLTx). Allograft recipients received injections rhIL-10 at doses 2, 10, 20, or 50 micrograms/kg/day. The allograft that 10 20 micrograms/kg/day showed a slight but significant prolongation to 13.0 +/- 0.4 13.8 0.3 days, respectively, compared with 9.6 0.2 days untreated allografts. Conversely, high-dose shortened survival. In treatment groups, mean serum tissue levels CINC every time point after OLTx were reduced significantly those no-treatment group. peak counts peripheral circulation (PC) groups given from samples obtained 12h reperfusion decreased Furthermore, PC between postoperative (PODs) 7 magnitude damage leukocyte infiltration rhIL-10-treated allografts on PODs 1 was Our data indicate downregulates during period injury acute cellular rejection OLTx, prolongs survival, suggesting IL-10 therapy is potentially beneficial OLTx.

参考文章(14)
P Wang, P Wu, JC Anthes, MI Siegel, RW Egan, MM Billah, Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood. ,vol. 83, pp. 2678- 2683 ,(1994) , 10.1182/BLOOD.V83.9.2678.2678
Calne Ry, Kamada N, A surgical experience with five hundred thirty liver transplants in the rat. Surgery. ,vol. 93, pp. 64- ,(1983)
C A Dinarello, A R Rabson, E V Granowitz, S M Wolff, J B Angel, A E Chernoff, J S Kennedy, G Lonnemann, E Vannier, L Shapiro, A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. Journal of Immunology. ,vol. 154, pp. 5492- 5499 ,(1995)
L Franksson, F Salazar-Onfray, K Kärre, M Petersson, R Kiessling, M Matsuda, T Blankenstein, IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. Journal of Immunology. ,vol. 154, pp. 6291- 6298 ,(1995)
Nobuaki Sekido, Naofumi Mukaida, Akihisa Harada, Isao Nakanishi, Yoh Watanabe, Kouji Matsushima, Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 Nature. ,vol. 365, pp. 654- 657 ,(1993) , 10.1038/365654A0
Junhong Sun, A. G. Ross Sheil, Chuanmin Wang, Lisheng Wang, Karen Rokahr, Alexandra Sharland, Sung-Eun Jung, Li Li, Geoffrey W. McCaughan, G. Alex Bishop, Tolerance to rat liver allografts: IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation. ,vol. 62, pp. 1725- 1730 ,(1996) , 10.1097/00007890-199612270-00005
MANFRED HUMMEL, SILVIA CZERLINSKI, NORBERT FRIEDEL, CHRISTA LIEBENTHAL, DIETER HASPER, RUDIGER VON BAEHR, ROLAND HETZER, HANS-DIETER VOLK, Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation Critical Care Medicine. ,vol. 22, pp. 448- 454 ,(1994) , 10.1097/00003246-199403000-00015
Anne Delvaux, Vincent Donckier, Catherine Bruyns, Sandrine Florquin, Catherine Gérard, Zoulikka Amraoui, Daniel Abramowicz, Michel Goldman, Thierry Velu, Effects of systemic administration of rIL-10 in an in vivo model of alloreactivity. Transplantation. ,vol. 58, pp. 972- 974 ,(1994) , 10.1097/00007890-199410270-00025
DAVID H. ADAMS, LIAN FU WANG, DAVID BURNETT, ROBERT A. STOCKLEY, JAMES M. NEUBERGER, Neutrophil activation--an important cause of tissue damage during liver allograft rejection? Transplantation. ,vol. 50, pp. 86- 91 ,(1990) , 10.1097/00007890-199007000-00016
R de Waal Malefyt, J Haanen, H Spits, M G Roncarolo, A te Velde, C Figdor, K Johnson, R Kastelein, H Yssel, J E de Vries, Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. Journal of Experimental Medicine. ,vol. 174, pp. 915- 924 ,(1991) , 10.1084/JEM.174.4.915